Dane Bedward

Mr. Dane Bedward is the CEO of NeuroBot Inc., a strategic advisory company focused on assisting Medtech, Digital Medicine and Biopharma companies with their business strategies. Prior to founding his advisory company, Dane was Senior Vice President International for Genzyme Corporation, one of the top 5 global biotech companies before to being acquired by Sanofi-Aventis. His first assignment with Genzyme was as Managing Director and President of the Canadian subsidiary Genzyme Canada Inc. Genzyme Corporation is a pioneer in the development of products for rare genetic diseases.Throughout his career Mr. Bedward has also worked with other organizations such as Nordion International, Johnson and Johnson (in Canada and Europe), Flow Laboratories, and McMaster University. Dane serves on the Board of Directors of The National Angel Capital Organization (NACO), The Capital Angel Network (CAN), and Panthera Cryosolutions, as well as chairs the Board of Directors for Spiderwort Inc.